Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of Tau protein

被引:0
|
作者
Virgilio, E. [1 ]
Vecchio, D. [1 ]
Crespi, I. [2 ]
Barbero, P. [1 ]
Galli, G. [1 ]
Cantello, R. [1 ]
Dianzani, U. [2 ]
Comi, C. [1 ]
机构
[1] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
[2] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P607
引用
收藏
页码:530 / 531
页数:2
相关论文
共 50 条
  • [31] Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients
    Valis, Martin
    Talab, Radomir
    Stourac, Pavel
    Andrys, Ctirad
    Masopust, Jiri
    NEUROENDOCRINOLOGY LETTERS, 2008, 29 (06) : 971 - 976
  • [32] Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein
    Grangeon, Lou
    Paquet, Claire
    Bombois, Stephanie
    Quillard-Muraine, Muriel
    Martinaud, Olivier
    Bourre, Bertrand
    Lefaucheur, Romain
    Nicolas, Gael
    Dumurgier, Julien
    Gerardin, Emmanuel
    Jan, Mary
    Laplanche, Jean-Louis
    Peoc'h, Katell
    Hugon, Jacques
    Pasquier, Florence
    Maltete, David
    Hannequin, Didier
    Wallon, David
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (03) : 905 - 913
  • [33] Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis
    Zido, Michal
    Kacer, David
    Vales, Karel
    Zimova, Denisa
    Stetkarova, Ivana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [34] CSF Tau protein correlates with cognitive impairment in multiple sclerosis patients at diagnosis
    Virgilio, Eleonora
    Vecchio, Domizia
    Crespi, Ilaria
    Barbero, Paolo
    Galli, Giulia
    Cantello, Roberto
    Dianzani, Umberto
    Comi, Cristoforo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [35] Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
    Khalil, M.
    Riedlbauer, B.
    Langkammer, C.
    Enzinger, C.
    Ropele, S.
    Stojakovic, T.
    Scharnagl, H.
    Culea, V.
    Petzold, A.
    Teunissen, C.
    Archelos, J. -J.
    Fuchs, S.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 545 - 545
  • [36] Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
    Khalil, M.
    Riedlbauer, B.
    Langkammer, C.
    Enzinger, C.
    Ropele, S.
    Stojakovic, T.
    Scharnagl, H.
    Culea, V.
    Petzold, A.
    Teunissen, C. E.
    Archelos, J-J
    Fuchs, S.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1569 - 1577
  • [37] Cerebrospinal fluid levels of IL-1β correlate with inflammatory cortical lesions in early stages of multiple sclerosis
    Gallo, P.
    Puthenparampil, M.
    Federle, L.
    Seppi, D.
    Miante, S.
    Poretto, V.
    Alessio, S.
    Calabrese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 500 - 500
  • [38] Cognitive Impairment in Glucocerebrosidase (GBA)-Associated PD: Not Primarily Associated With Cerebrospinal Fluid Abeta and Tau Profiles
    Lerche, Stefanie
    Schulte, Claudia
    Srulijes, Karin
    Pilotto, Andrea
    Rattay, Tim W.
    Hauser, Ann-Kathrin
    Stransky, Elke
    Deuschle, Christian
    Csoti, Ilona
    Lachmann, Ingolf
    Zetterberg, Henrik
    Liepelt-Scarfone, Inga
    Gasser, Thomas
    Maetzler, Walter
    Berg, Daniela
    Brockmann, Kathrin
    MOVEMENT DISORDERS, 2017, 32 (12) : 1780 - 1783
  • [39] Increased concentrations of apolipoprotein E and protein tau in cerebrospinal fluid of patients with multiple sclerosis
    Siekmeier, R
    Ommert, S
    Bergmann, S
    Demisch, L
    Jaross, W
    Gross, W
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 433 (06): : P206 - P206
  • [40] Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients
    Pitteri, Marco
    Magliozzi, Roberta
    Nicholas, Richard
    Ziccardi, Stefano
    Pisani, Anna Isabella
    Pezzini, Francesco
    Marastoni, Damiano
    Calabrese, Massimiliano
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 768 - 777